Listen to Medtech Insight podcasts for our perspectives on regulation, policy, quality, R&D and key commercial topics.
Navigate to our Medtech podcasts:
Medtech Monthly provides in-depth conversations, news highlights, exclusive discussions with subject matter experts, and more.
In this episode of Report Digest, UK-based reporter Barnaby Pickering speaks to analyst Carrie Neptune about three Meddevicetracker reports on drug delivery technology.
In this edition of the Medtech Monthly podcast, Epstein Becker Green attorney and data scientist Bradley Merrill Thompson spoke to Medtech Insight about this analysis of the efficacy of the US Food and Drug Administration's Breakthrough Devices program.
In this edition of Medtech Monthly, Robert Gabbay, chief scientific and medical officer for the American Diabetes Association talked to Medtech Insight about diabetes tech, where it's headed, and what it could mean for preventative care.
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
In this episode of Speaking Of Medtech: Over the past decade or so the US FDA and many device makers have been advocating for quality over compliance, but what if promoting compliance was seen as a good goal for the medtech industry?
In this episode of Speaking Of Medtech: Too often quality is overshadowed by regulatory and compliance, and some manufacturers view quality as an obstacle to getting product into the marketplace rather than a concept that will help a company save money, reputation, and patient lives.
This second Medtech Insight podcast on the basics of EU medical device regulation looks at the main EU organizations involved in medtech regulation, the four medical device risk classes, and the role of the key regulatory documents.
In this month’s Digital Health Roundup, Medtech Insight’s Reed Miller talks about Biotronik’s and AliveCor’s partnership, Marion Webb profiles three agetech companies, and Barnaby Pickering talks Swiss medtech awards and smart hospitals.
Getting Personal With De Oro Devices’ Sidney Collin: ‘There’s A Lot Of Learning That Needs To Happen’
In this new series titled Getting Personal, we talk to new and veteran executives about the trials and tribulations in running a company while exploring their own motivations and passions. In this first edition, we talk to Sidney Collin, co-founder and CEO of De Oro Devices. Collin invented NexStride, a portable device to help overcome freezing of gait in Parkinson’s disease patients, while studying biomedical engineering at the California Polytechnic State University in 2018.
Medtech Insight reporters and editors offer additional perspective on the biggest medtech news of the week.
“The sky’s the limit in terms of what’s possible within smart hospitals,” according to Brad Genereaux, global lead of health care alliances at NVIDA. He and Roger Lam, director of engineering at hardware manufacturers MBX systems, spoke to Medtech Insight about the potential of smart hospitals and what needs to be done to create them.
In this FINAL edition of Device Week, Medtech Insight’s Barnaby Pickering discusses recent developments in the highly competitive continuous glucose monitoring space and editor Marion Webb explains the application of robotics to common blood sampling.
Device Week, 13 April 2022 – Highlights From Miach And Outset Exec Chats; Medtronic’s Update On Renal Denervation Trials
In this edition of Device Week, Medtech Insight’s Marion Webb reviews her recent interviews with Martha Shadan, the CEO of Miach Orthopaedics, and Outset Medical’s CEO Leslie Trigg. Reed Miller has an update on Medtronic’s long-awaited renal denervation technology.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.